psoriasis: the new skin
DESCRIPTION
Psoriasis: The New Skin. Paris Fears Queens University of Charlotte SPAEP I Pittsburgh , PA. Psoriasis. Table of Contents. Introduction What is Psoriasis Background Epidemiology Genetics Physiology Quality of Life Treatments Conclusion Questions. - PowerPoint PPT PresentationTRANSCRIPT
Psoriasis: The New SkinParis Fears
Queens University of CharlotteSPAEP I Pittsburgh, PA
Psoriasis
•‘Psora’ means to itch in Greek
•Gain an understanding of the disease, Psoriasis
IntroductionWhat is Psoriasis
BackgroundEpidemiology
Genetics Physiology
Quality of LifeTreatmentsConclusion Questions
Table of Contents
Psoriasis
•Psoriasis, a chronic non-infectious immune-mediated inflammatory skin condition that causes thick red and flaky patches of skin
•Natural Course•5 common types
Questions
IntroductionWhat is Psoriasis
BackgroundEpidemiology
GeneticsPhysiology
Quality of LifeTreatmentsConclusionQuestionsReferences
Table of Contents
IntroductionWhat is Psoriasis
BackgroundEpidemiology
GeneticsPhysiology
Quality of LifeTreatmentsConclusion QuestionsReferences
Table of Contents
Psoriasis
•Psoriasis, a chronic non-infectious immune-mediated imflammatory skin condition that causes thick red and flaky patches of skin
•Natural Course•5 common type
IntroductionWhat is Psoriasis
BackgroundEpidemiology
GeneticsPhysiology
Quality of LifeTreatmentsConclusionQuestions
References
Table of Contents
Plaque*-basic dry, itchy, red skin in common sites Guttate- proceeds after strep throat; numerous red scaly bumpsInverse*- occurs in excess skin folds and soft tissuePustular- small pus filled bumps on whole body or hands and feetErythrodermic- aggressive plaque with pain and wide patches on entire body
Psoriasis
•Mistoken for 150 years• 1700’s to 1800’s Robert
Willian and Jacob Plenck•1841 Ferdinand von
Hebra
IntroductionWhat is Psoriasis
BackgroundEpidemiology
GeneticsPhysiology
Quality of LifeTreatmentsConclusionQuestionsReferences
Table of Contents
Psoriasis
•7.5-8.5 million •125 million •150,000•<400, >400•Everyone is at risk
IntroductionWhat is Psoriasis
BackgroundEpidemiology
GeneticsPhysiology
Quality of LifeTreatmentsConclusion QuestionsReferences
Table of Contents
IntroductionWhat is Psoriasis
BackgroundEpidemiology
GeneticsPhysiology
Quality of LifeTreatmentsConclusionQuestions
References
Table of Contents
•40% increase in risk of contracting Psoriasis with "familial tendency" •Identical Twins incidence
Psoriasis•Psoriasis triggers•Stress•Little Sun Light•Injury to skin•Medication•Immune system
deficiencies
IntroductionWhat is Psoriasis
BackgroundEpidemiology
GeneticsPhysiology
Quality of LifeTreatmentsConclusionQuestionsReferences
Table of Contents
PsoriasisIntroduction
What is PsoriasisBackground
EpidemiologyGenetics
PhysiologyQuality of Life
TreatmentsConclusionQuestions
References
Table of Contents
PsoriasisIntroduction
What is PsoriasisBackground
EpidemiologyGenetics
PhysiologyQuality of Life
TreatmentsConclusionQuestionsReferences
Table of Contents
Psoriasis•$1.6 billion to $4.3 billion
dollars•75% believe in negative
impact•Comorbidities
• HIV
• CVD
• Obesity and Alcohol Abuse
IntroductionWhat is Psoriasis
BackgroundEpidemiology
GeneticsPhysiology
Quality of LifeTreatmentsConclusionQuestions
References
Table of Contents
Psoriasis•Controlled not Cured•Topical treatments•Home remedies•Pills•Alternative treatments
IntroductionWhat is Psoriasis
BackgroundEpidemiology
GeneticsPhysiology
Quality of LifeTreatmentsConclusionQuestions
References
Table of Contents
Summary• Prevalent in all genders races,
and ages 3-95
• Effects about 125 million people worldwide
• Complex auto-immune inflammatory skin condition which includes, white scaly and raised red lesions
• Triggers include anything from bacterial and viral infection to stress
• The exact schematics to cure this disease are still a mystery
IntroductionWhat is Psoriasis
BackgroundEpidemiology
GeneticsPhysiology
Quality of LifeTreatmentsConclusionQuestions
References
Table of Contents
QUESTIONS?
IntroductionWhat is Psoriasis
BackgroundEpidemiology
GeneticsPhysiology
Quality of LifeTreatmentsConclusionQuestionsReferences
Table of Contents
IntroductionWhat is Psoriasis
BackgroundEpidemiology
GeneticsPhysiology
Quality of LifeTreatmentsConclusionQuestions
References
Table of Contents References
• Babu, Hanish. "History of Psoriasis.” General Medicine (suite 101) (2008): n. pag. Web. 17 Jul 2011. http://www.suite101.com/content/history-of-psoriasis-a85546. • Bhosle, Monali J, Amit Kulkarni, Steven R Feldman,
and Rajesh Balkrishnan. "Quality of life in patients with psoriasis." Health and Quality of Life Outcomes 4.35 (2006): Web. 17 Jul 2011. http://www.hqlo.com/content/4/1/35>. • Kurian, Anil, and Benjamin Barankin. "Current
Effective Topical Therapies in the Management of Psoriasis." Skin Therapy Letter 16.1 (2011): 4-7. Web. 26 Jun 2011.http://www.skintherapyletter.com/2011/16.1/2.html.• Schön, Michael P, and W.-Henning Boehncke.
"Psoriasis." N Engl J Med 352. (2005): n. pag. Web. 17 Jul 2011. http://www.nejm.org/doi/full/10.1056/NEJMra041320#t=article.